Cabazitaxel Impresses in Locally Advanced De-Differentiated Liposarcoma

(MedPage Today) -- Progression-free survival (PFS) results with cabazitaxel (Jevtana) in metastatic or inoperable locally advanced de-differentiated liposarcoma (DDLPS) suggest the drug should be studied further in this setting, according to investigators...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news